In an article published online on April 1, 2009 in the journal Cell Division, Egyptian researchers report that the omega-3 fatty acid docosahexaenoic acid (DHA), found in fish and the algae they consume, not only offers its own protection against tumor growth, but improves the chemotherapeutic effects of cisplatin while reducing its toxicity.
Professor A. M. El-Mowafy of Mansoura University’s Department of Biochemistry and associates administered 125 milligrams per kilogram (mg/kg) DHA, 250 mg/kg of DHA, cisplatin alone, cisplatin combined with 125 mg/kg DHA, or a control substance to groups of 8 to 10 mice implanted with mammary carcinoma cells. A group of mice not implanted with tumor cells served as controls. Serum C-reactive protein (CRP, a marker of inflammation), white blood cells, and MDA (a marker of lipid peroxidation) were measured, and tumor development was assessed after 20 days.
Mice injected with cancer cells experienced significantly elevated levels of C-reactive protein, white blood cells, and lipid peroxidation compared with control mice. These levels were reduced in animals that received cisplatin and/or DHA. While treatment with 125 mg/kg DHA inhibited tumor growth by 38 percent compared to untreated animals, 250 mg/kg suppressed tumor growth by 79 percent, which was a greater effect than that of cisplatin alone (which was associated with a 55 percent reduction). The combination of DHA and cisplatin resulted in an 81 percent inhibition of growth, while reducing elevated white blood cell levels (leukocytosis) to normal levels. Treatment with the higher dose of DHA alone was associated with a similar reduction in white blood cells, which, when elevated, are associated with tumor growth. A strong relationship was observed between tumor growth and white blood cell levels as well as C-reactive protein levels.
In another experiment with rats treated with cisplatin, the addition of 250 mg/kg DHA prevented lethal kidney toxicity in 88 percent of the animals that received it, while none of the rats that received cisplatin alone survived.
"DHA elicited prominent chemopreventive effects on its own, and appreciably augmented those of cisplatin as well," Dr El-Mowafy commented. "Furthermore, this study is the first to reveal that DHA can obliterate lethal cisplatin-induced nephrotoxicity and renal tissue injury."
"The chemoprevention elicited by DHA was dose-dependent, and appeared to be mediated by reduction of leukocytosis, oxidative stress, and replenishing of endogenous antioxidant machinery," the authors write. "Most strikingly, a strong anti-inflammatory effect was produced that was highly reflected by reduction in CRP level. We provided novel, strong evidence that CRP serves as a sensitive diagnostic/prognostic marker both for tumor progression and responsiveness to chemotherapy in solid tumors."
"In essence, the renal protective and animal rescuing effects obtained for DHA, as well as its capacity to ameliorate leukocytosis, oxidant stress and inflammation, further substantiate its produced chemoprevention/chemo-enhancing profiles," they conclude. "This could, therefore, suggest a new fruitful drug regimen in the management of solid tumors based on combining cisplatin with DHA."
According to the National Cancer Institute, almost all normal cells grow and die in a controlled way through a process called apoptosis. Cancer cells, on the other hand, keep dividing and forming more cells without a control mechanism to induce normal apoptosis.
Anticancer drugs destroy cancer cells by stopping them from growing or dividing at one or more points in their growth cycle. Chemotherapy may consist of one or several cytotoxic drugs that kill cells by one or more mechanisms. The chemotherapy regimen chosen by most conventional oncologists is based on the type of cancer being treated.
The goal of chemotherapy is to shrink primary tumors, slow the tumor growth, and kill cancer cells that may have spread (metastasized) to other parts of the body from the original, primary tumor. However, chemotherapy kills both cancer cells and healthy normal cells. Oncologists try to minimize damage to normal cells and to enhance the cell killing (cytotoxic) effect on cancer cells. Too often, unfortunately, this delicate balance is not achieved.
In another study, a group of dogs with lymphoma were randomized to receive either a diet supplemented with arginine and fish oil or just soybean oil. Dogs on the fish oil and arginine diet had a significantly longer disease-free survival time than dogs on the soybean oil (Ogilvie et al. 2000).
Adequate intake of vitamins and minerals is key to optimal health. But, since it is virtually impossible to eat enough food to get all the nutrients the body needs on a daily basis, taking multivitamin supplements is the healthy alternative. That is why Life Extension developed Life Extension Mix™ back in 1983. However, some people are averse to swallowing the nine tablets per day recommended to get the maximum health benefits demonstrated in scientific studies.
For those people, Life Extension has formulated a two-per-day multivitamin supplement that provides the maximum amount of active ingredients that can fit into two tablets.
In Germany, doctors are recommending a natural extract from the herb butterbur (Petasites hybridus) to those who suffer from regular episodes of head cavity discomfort. In clinical trials in both Germany and the United States, butterbur reduced the incidence of head cavity discomforts by up to 61%.
Butterbur’s principal active constituent, petasin, reduces smooth muscle spasms and helps relax the constriction of cerebral blood vessels. Butterbur’s ability to relax constricted arteries and smooth muscle may help control head cavity discomfort.